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g) was dissolved in acetone (50 ml) at room temperature. Colourless crystals of the title compound (I) were obtained through slow evaporation after two weeks.
Refinement
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4-Bromo
-5-[(5,5-dimethyl-4,5-dihydroisoxazol-3-yl)sulfonylmethyl]-3-methyl-1-(2,2,2-trifluoroethyl)-1H-
Geometric parameters (Å, °)
Br1-C1 1.868 (2) C4-H4B 0.9800 S1-O1 1.4346 (17) C4-H4C 0.9800 S1-O2 1.4351 (18) C5-C6 1.509 (3) S1-C8 1.767 (2) C5-H5A 0.9900 S1-C7 O1-S1-O2 119.28 (11) F1-C6-C5 110.8 (2) O1-S1-C8 106.41 (11) F2-C6-C5 112.2 (2) O2-S1-C8 109.30 (10) F3-C6-C5 112.5 (2) Hydrogen-bond geometry (Å, °) supplementary materials sup-7 Fig. 1 
